Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 13/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.35 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | XBP1 | P17861 | 1/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29211208 | 0.98 | FAAH (0.45) | FAAHCA2TSHRCA1CA9 | |
| SCHEMBL2489357 | 0.93 | ALDH1A1 (0.41) | FAAHCA2NPC1S1PR2S1PR4 | |
| SCHEMBL1628446 | 0.89 | — | — | |
| SCHEMBL2486748 | 0.84 | — | — | |
| SCHEMBL3319916 | 0.83 | FAAH (0.39) | FAAHCA2NPC1S1PR2S1PR4 | |
| SCHEMBL27853475 | 0.82 | — | — | |
| SCHEMBL3295254 | 0.82 | FAAH (0.42) | FAAHCA2TSHRCA1CA9 | |
| SCHEMBL6247258 | 0.80 | FAAH (0.43) | FAAHCA2NPC1S1PR2S1PR4 | |
| Acrylic Acid Methyl Ester SCHEMBL15637751 | 0.79 | TSHR (0.43) | CA2NPC1S1PR2S1PR4ALDH1A1 | |
| SCHEMBL27881702 | 0.78 | FAAH (0.46) | FAAHCA2TSHRCA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116157152-A | Compositions and methods for improving the efficacy of a drug | 赫利昂生物股份有限公司 | 2023-05-23 | — | — | CN | claimed |
| WO-2009118753-A2 | PROCESS FOR PREPARATION OF NARATRIPTAN HYDROCHLORIDE | USV LIMITED (IN) | 2009-10-01 | — | — | WO | claimed |
| EP-0311799-A1 | Water dispersible hydrophobic thickening agent | AMERICAN CYANAMID COMPANY (US) | 1989-04-19 | — | — | EP | claimed |
| CN-116157152-A | Compositions and methods for improving the efficacy of a drug | 赫利昂生物股份有限公司 | 2023-05-23 | — | — | CN | disclosed |
| CN-112940432-B | Polymerizable monomer for dental material, composition, adhesive dental material, and kit | 三井化学株式会社 | 2022-12-30 | — | — | CN | disclosed |
| EP-3572202-B1 | MOLDED ARTICLE AND METHOD FOR PRODUCING SAME | SUMITOMO CHEMICAL CO (JP) | 2021-08-11 | — | — | EP | disclosed |
| CN-107427414-B | Polymerizable monomer for dental material, composition, adhesive dental material, and kit | 三井化学株式会社 | 2021-07-02 | — | — | CN | disclosed |
| CN-112940432-A | Polymerizable monomer for dental material, composition, adhesive dental material, and kit | 三井化学株式会社 | 2021-06-11 | — | — | CN | disclosed |
| US-10941254-B2 | Molded article and method of producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-03-09 | — | — | US | disclosed |
| US-20190322815-A1 | MOLDED ARTICLE AND METHOD OF PRODUCING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-10-24 | — | — | US | disclosed |
| US-20190033503-A1 | LIGHT-MODULATING MEMBER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-01-31 | — | — | US | disclosed |
| EP-2924228-B1 | LIGHT-MODULATING MEMBER | SUMITOMO CHEMICAL CO (JP) | 2018-10-24 | — | — | EP | disclosed |
| US-20150309227-A1 | LIGHT-MODULATING MEMBER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-10-29 | — | — | US | disclosed |
| EP-2924228-A1 | LIGHT-MODULATING MEMBER | Sumitomo Chemical Company Limited (JP) | 2015-09-30 | — | — | EP | disclosed |
| CN-1809615-B | Transparent resin composition | SANYO CHEMICAL IND LTD | 2010-05-05 | — | — | CN | disclosed |
| US-20090258966-A1 | Dental Composition | NIHON UNIVERSITY (JP) | 2009-10-15 | — | — | US | disclosed |
| WO-2009118753-A2 | PROCESS FOR PREPARATION OF NARATRIPTAN HYDROCHLORIDE | USV LIMITED (IN) | 2009-10-01 | — | — | WO | disclosed |
| CN-1809615-A | Transparent resin composition | SANYO CHEMICAL IND LTD (JP) | 2006-07-26 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090258966-A1 | Dental Composition | DCPS, MMAB, CAD | FAAH 4656/4885CA2 149/4885NPC1 4650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.